The potential of adiponectin in driving arthritis
A recent article in by Ehling and colleagues in the Journal of immunology looked into the potential that adiponectin has in driving arthritis.
Little is known about the local functions of articular adipose tissue (a ubiquitous component in human joints). Many recent publications have put forward possible links between adipocytokines, adipose tissue and arthritis. Ehling and friends looked at the ‘the adipocytokine adiponectin and its functional role in articular adipose tissue and synovium of patients with different arthritides’.
They found that ‘in contrast to its protective role in endocrinological and vascular diseases, adiponectin was found to be involved in key pathways of inflammation and matrix degradation in the human joint’
and that ‘ the effects of adiponectin in human synovial fibroblasts appear to be highly selective by inducing only two of the main mediators of rheumatoid arthritis pathophysiology, IL-6 and matrix metalloproteinase-1, via the p38 MAPK pathway’.
This led them to suggest that adipocytokines may be key targets in future therapeutic strategies in inflammatory joint diseases.
The full article is availble form pubmed PMID: 16547285 [PubMed - in process]









